FDA pharmacologic class
P2Y12 inhibitors (antiplatelets)
4 medicines are in FDA's class of p2y12 platelet inhibitors (p2y12 inhibitors): clopidogrel (Plavix), ticagrelor (Brilinta), prasugrel (Effient) and cangrelor (Kengreal). All 4 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is clopidogrel 75 mg tablet at $0.0472 per tablet (NADAC).
Which medicines are p2y12 inhibitors?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Clopidogrel | Plavix | 35 labelers | $0.0472 per tablet 75 mg tablet | Yes | No current entry | 6 |
| Ticagrelor | Brilinta | 28 labelers | $0.253 per tablet 90 mg tablet | Yes | No current entry | 2 |
| Prasugrel | Effient | 10 labelers | $0.263 per tablet 10 mg tablet | Yes | No current entry | 5 |
| Cangrelor | Kengreal | 1 labeler | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price